hs-cTnT is a specific and sensitive biomarker of myocardial damage and is being widely used for clinical screening in patients with suspected acute myocardial infarction [41, 42], but not for evaluating the change of myocardial contractility. Here, TNNT2 is linked to myocardial infarction.